Loading organizations...
Hansongneotech develops and manufactures specialized equipment essential for advanced display production. The company provides total solutions for metal mask processing, a core component in AMOLED cell technology. Its machinery supports complex manufacturing requirements for flat panel displays, enabling precise and efficient production for the global display industry.
Established in 1996, Hansongneotech originated in Gumi, Gyeongsangbuk-do, South Korea. The company began operations focusing on essential machinery for the nascent display sector. While specific founder details remain undisclosed, its consistent presence indicates a foundational commitment to supporting display manufacturing advancements since its early establishment.
The company's products are utilized by prominent entities within the display industry, including major global manufacturers. Hansongneotech’s offerings enable these producers to enhance their capabilities for advanced display technologies. Its long-term vision centers on providing critical equipment and solutions that contribute to the evolution and expansion of the global flat panel display market.
Hansongneotech has 1 tracked investment across 1 company. The latest tracked deal is $26.2M Grant / Series B in PDC*line Pharma in December 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 6, 2021 | PDC*line Pharma | $26.2M Grant / Series B | Sangwoo LEE | Alpha Holdings, Brain Asset Management, Noshaq, Sambrinvest, Fontaine François, Smart Korea UTC BIO Healthcare Venture Fund, Sriw, Walloon Region |